Dawn Sauro
InvestorSenior Advisor at InTandem Capital Partners
Saunderstown, Rhode Island, United States
About
Dawn Sauro has over 30 years of experience in drug and device development. She previously served as Chief Growth Officer at WCG Clinical, COO at Elligo Health Research, and Chief Development Officer at Clinipace (now Caidya), and held earlier roles as President, Development Innovations at Sarah Cannon and SVP & General Manager of Hematology and Oncology at inVentiv Health (now Syneos).
Experience
- InTandem Capital PartnersSenior Advisorcurrent2026 β present
- ScoutMember Board of Directorscurrent2026 β present
- ScoutAdvisory Board Member2024 β 2026
- Istios HealthAdvisory Board Membercurrent2026 β present
- Univo IRBMember Board of Directorscurrent2025 β present
- PreludeOperating Advisorcurrent2025 β present
- ClinilabsMember Board of Directorscurrent2025 β present
- Kolos PartnersOperating Advisorcurrent2024 β present
- DS Clinical ConsultingPresidentcurrent2024 β present
- ScienceMedia, Inc. (SMi)Advisory Board Membercurrent2025 β present
- WCGChief Growth Officer2023 β 2024Princeton, New Jersey, United States
- Deep 6 AIMember Board of Directors2023 β 2024
- Elligo Health ResearchChief Operating Officer2023Saunderstown, Rhode Island, United States
- Elligo Health ResearchExecutive Vice President, Research Strategy2022 β 2023Saunderstown RI
- Clinipace WorldwideChief Development Officer2018 β 2022Raleigh, North Carolina, United States
- Sarah Cannon Research InstitutePresident, Development Innovations2015 β 2018Nashville, Tennessee, United States
- inVentiv Health ClinicalSenior Vice President and General Manager, Hematology and Oncology2012 β 2015Raleigh, North Carolina, United States
- PRA InternationalVice President and General Partner - Operations2008 β 2012Raleigh-Durham-Chapel Hill Area
- PPDDirector, Clinical Operations2006 β 2008Wilmington NC and Seattle WA
- PPDAssociate Director Clinical Operations2004 β 2006Wilmington, North Carolina, United States
Education
- University of Rhode IslandBachelor of Science - BS
Skills & more
Strategic ThinkingOperations ManagementProject ManagementStrategic PartnershipsEmployee EngagementOperational EfficiencyCustomer EngagementOrganization Re-structuringTurn Around ManagementBusiness TransformationRevenue and ProfitCommerical Strategy
+12 more
Sales ProcessesRevenue & Profit GrowthPolicies & ProceduresStrategic PlanningCommercial StrategyTeam LeadershipSales Team RestructuringSales TrainingsGo-to-Market StrategyEDCTherapeutic AreasClinical DevelopmentFrom Dawn's professional profile.
Colleagues at InTandem Capital Partners
Aaron Newman
Principal at InTandem Capital Partners
Adam Boorstein
Vice President at InTandem Capital Partners
Amy Wilson
Portfolio Monitoring Lead at InTandem Capital Partners
Bob Patricelli
Senior Advisor at InTandem Capital Partners
Bob Subasic
Operating Partner at InTandem Capital Partners
Brad Coppens
President, Managing Partner at InTandem Capital Partners
Brent McCarty
Senior Advisor at InTandem Capital Partners
Carla Arellano
Operating Partner, Human Capital at InTandem Capital Partners
Frequently asked questions
- Where does Dawn Sauro work?
- Dawn Sauro is Senior Advisor at InTandem Capital Partners.
Same school
Also attended University of Rhode Island23
Job SimonVenture Partner and CTO at Monta Vista CapitalScott FrechetteInvestor at Third Rock VenturesAbe MurrayGeneral Partner at AlleyCorpDave BarrettSenior Advisory Partner at Polaris PartnersRhonda PachecoPresident, U.S. Business Unit and U.S. Country Head at Takeda VenturesKalyn SchiefferPrincipal, Public Relations at Anzu Partners
+ 17 more
Shared employers
Also worked at Elligo Health Research4
Also worked at Clinipace Worldwide1
Also worked at Pfizer142
Jigar RaythathaInvestor at Third Rock VenturesAbbie CelnikerInvestor at Third Rock VenturesJeb KeiperInvestor at Third Rock VenturesRichard ChesworthInvestor at Third Rock VenturesBriggs MorrisonEntrepreneur Partner at MPM BioImpactJohn McKearnSenior Advisor at RiverVest Venture Partners, focused on early-stage biotech
+ 136 more




















